Dear Editor,

The world has been the stage for a new coronavirus, officially named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing the coronavirus disease 2019 (COVID-19). As the discovery of SARS-CoV-2 is very recent, there are few reliable studies on the long-term consequences of exposures of this virus. In view of this turbulent global scenario and the need for more research, it is clear that a greater focus on this theme is urgent.

Currently, 7 human coronaviruses have been identified, among which were previously described severe acute respiratory syndrome-CoV (SARS-CoV) and Middle East respiratory syndrome-CoV (MERS-CoV), the 2 most recognized following the outbreaks in 2003 and 2012, respectively \[[@CR1]\].

The structural homology of SARS-CoV-2 with SARS and the similarity in their clinical conditions have been noted, leading us to believe that individuals infected by SARS-CoV-2 may present abnormalities similar to those presented in SARS. A number of studies highlighted several sequelae after the acute phase of SARS related to radiological and functional abnormalities, such as shortness of breath and disturbed sleep \[[@CR2]--[@CR4]\].

Until now, it is known that SARS-CoV-2 is responsible for leading to acute respiratory distress syndrome, kidney and heart failure, liver damage, shock, and multiple organ failure \[[@CR5]\]. The severity of symptoms in COVID-19 may be associated with a pro-inflammatory cytokine storm, also seen in SARS, which is responsible to generate the systemic inflammation \[[@CR5]\]. A higher serum concentration of these cytokines in patients in intensive care units corroborates this possible relationship \[[@CR6]\]. The severity of the clinical presentation also appears to be related to the underlying diseases, such as cardiovascular diseases and obstructive sleep apnea (OSA) \[[@CR5], [@CR7]\]. A recent study proposed that OSA, the most common sleep-related breathing disorder, may be one of these conditions that can be considered a potential risk factor for severe COVID-19 \[[@CR7]\].

The long-term impact of COVID-19 is still under investigation, and little is known about how the immune system recovers after infection. Scientific evidence suggests the possibility of a high residual viral load of SARS-CoV-2 in convalescent patients \[[@CR8]\]. So far, clinical studies have been shown the occurrence of extensive lung damage, pulmonary inflammation, and hyperinflammatory response of the body \[[@CR5], [@CR6], [@CR9]\]. However, long-term follow-up is needed to determine whether this impairment of lung tissue is irreversible. Besides, studies have shown that coronaviruses are capable of infecting neurons by binding to the angiotensin-converting enzyme receptor 2 (ACE2) expressed by neural cells. These receptors are also found in the lung, small bowel, and vasculature, among others \[[@CR3], [@CR10], [@CR11]\].

The entry of the coronavirus into the central nervous system and peripheral tissues can lead to respiratory insufficiency due to neuroinvasion in the brainstem, responsible for cardiorespiratory control \[[@CR10]\]. The prolonged effects of impaired respiratory regulation, due to neurological injury, can result in a worsening of the quality of sleep in patients recovering from COVID-19, since there is a close relationship between breathing disorders and sleep \[[@CR12]\]. In this sense, the infection can also play a role in the appearance of sleep disorders in survivors after SARS-CoV-2.

Supporting the concern with post-infection sleep quality, a study in Toronto, Canada (2011), identified, among other symptoms, changes in sleep patterns in post-SARS patients. An increase in nonrestorative sleep with associated REM-related apneas/hypopneas, a high alternating cyclic pattern of sleep EEG and anomaly of alpha EEG sleep, was observed \[[@CR4]\]. Due to the similarities in the pathophysiological processes, SARS-CoV-2 may also cause these sleep changes.

The long-term adverse effects of COVID-19 are unknown, so further clinical trials focusing on possible pulmonary sequelae, sleep patterns, and neurocognitive and neuropsychiatric impairment of these patients are necessary. We would like to emphasize that neurological injury caused by coronaviruses can lead to damage to respiratory regulation, which is close to breathing-related sleep disorders. In this sense, a worsening of sleep quality in patients recovering from COVID-19 may occur. In a scenario in which the number of cases and cured cases rises significantly every day, it is crucial that particular attention is given to the recuperation of patients infected with SARS-CoV-2.
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